Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

West Pharmaceutical and Pharmalink to develop IgA-nephropathy treatment

Feb. 26, 2004

Rockwell receives grant for proprietary dialysate iron therapy study

Feb. 25, 2004

DA-8159 effective for inducing erection in rabbit models of spinal cord injury

Feb. 16, 2004

New beta3-adrenoceptor agonists and their use in urinary incontinence

Feb. 13, 2004

Yamanouchi presents new inhibitors of reverse Na+/Ca2+ exchange

Feb. 12, 2004

Comparable results in phase II head-to-head study of TA-1790 and Viagra

Feb. 11, 2004

New PDE5 inhibitors claimed by Janssen scientists

Feb. 9, 2004

European submission for YM-617 TOCAS

Feb. 4, 2004

NDA submission for YM-087 for hyponatremia

Feb. 4, 2004

NX-1207 produces significant clinical improvement in BPH

Feb. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...